Clinical characteristic and treatment of BK virus infection in kidney transplant recipients at organ transplantation Center of Viet Duc Hospital

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     68    62

Abstract

Background: BK virus is one of the most infection cause of kidney graft damage and irreversible loss of graft function. There is currently no specific treatment regimen for BK virus, it is necessary to detect the activity of BK virus in patients early, especially in the early stages after transplantation. The study aimed to evaluate the diagnostic characteristics and treatment of BK virus infection in kidney transplant patients at the Organ Transplant Center, Viet Duc University Hospital.

Methods: Patients who received a kidney transplant and were followed up at the Organ Transplant Center, Viet Duc University Hospital from January 2015 to September 2021.

Results: The rate of blood BK infection ranges from 2.0 - 12.7%. Highest in the 3rd and 6th months. This rate gradually decreases after 12 months. The rate of urinary BK infection ranges from 13.3 - 35.3%. Most cases responded to immunosuppressant dose reduction, accounting for 85/106 patients (80.2%). There were 4 cases (3.77%) that did not respond to the treatment and were diagnosed with BKV kidney disease by kidney biopsy, including 2 patients with kidney transplant failure who had to undergo dialysis. In the group with active BK infection, after 6 months there was clearly kidney damage, shown by a sudden increase in blood creatinine.

Conclusion: BK virus infection cause allograft dysfunction and graft loss. The management of BKV infection in renal transplant recipients is not yet clearly defined. However, early recognition of urological sequelae and modification of immunosuppressive therapy are essential to ensure adequate long - term function of these allografts. Currently, there is no specific drug to treat BKV, some drugs have supportive effects but are not very effective, have many side effects or are expensive such as IVIG, quinolones, leflunomide, cidofovir.

https://doi.org/10.38103/jcmhch.93.1

References

Gonzalez S, Escobar-Serna D, Suarez O, Benavides X, Escobar-Serna J, Lozano E. BK virus nephropathy in kidney transplantation: an approach proposal and update on risk factors, diagnosis, and treatment. in Transplantation Proceedings. 2015. Elsevier.

Sawinski D , Goral S. BK virus infection: an update on diagnosis and treatment. Nephrology Dialysis Transplantation. 2015;30(2):209-217.

Huang G, Zhang L, Liang X, Qiu J, Deng R, Li J, et al. Risk factors for BK virus infection and BK virus–Associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction. in Transplantation proceedings. 2014. Elsevier.

Skulratanasak P, Mahamongkhonsawata J, Chayakulkeereeb M, Larpparisutha N, Premasathiana N, Vongwiwatana. A. BK Virus Infection in Thai Kidney Transplant Recipients: A Single-Center Experience. Transplant Proc. 2018;50(4):1077-1079.

Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488-96.

Thakur R, Arora S, Nada R, Minz M, Joshi K. Prospective monitoring of BK virus reactivation in renal transplant recipients in North India. Transpl Infect Dis. 2011;13(6):575-83.

Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation. 2008;85(6):850-4.

Li P, Cheng D, Wen J, Xie K, Li X, Ni X, et al. Risk factors for BK virus infection in living-donor renal transplant recipients: a single-center study from China. Ren Fail. 2018;40(1):442-446.

Ziedina I, Folkmane I, Chapenko S, Murovska M, Sultanova A, Jushinskis J, et al. Reactivation of BK Virus in the Early Period After Kidney Transplantation. Transplant Proc. 2009;41(2):766-8.

Huang G, Zhang L, Liang X, Qiu J, Deng R, Li J, et al. Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction. Transplant Proc. 2014;46(10):3448-54.

Ji J, Feng S, Jiang Y, Wang W, Zhang X. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study. Exp Clin Transplant. 2019;17(6):727-731.

He Q, Wu X, Li L, Qin W, Liang Z, Xie L, Relationships between acute rejection, hemoglobin levels and BK virus infection among renal transplant recipients in China. 2022, Research Square.

Published 08-12-2023
Fulltext
PDF (Tiếng Việt)     68    62
Language
Issue No. 93 (2024)
Section Original article
DOI 10.38103/jcmhch.93.1
Keywords BK virus, giảm liều thuốc ức chế miễn dịch, ghép thận BK virus, immunosuppressant dose reduction, kidney transplant

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Journal of Clinical Medicine Hue Central Hospital

Tuan, T. M., Vu, L. N., Anh, H. T., & Hai, P. T. (2023). Clinical characteristic and treatment of BK virus infection in kidney transplant recipients at organ transplantation Center of Viet Duc Hospital. Journal of Clinical Medicine Hue Central Hospital, (93), 5–10. https://doi.org/10.38103/jcmhch.93.1